MOTS-c: What makes this mitochondrial peptide different?

Hong Kong Yanpep International

BP BioLabs

Member

MOTS-c: What makes this mitochondrial peptide different?​

MOTS-c is an interesting topic in metabolic research because it originates from an unexpected place: the mitochondrial genome.

Unlike most peptides encoded by nuclear DNA, MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region.

What does the research suggest?​

The original 2015 study by Lee et al., published in Cell Metabolism, investigated MOTS-c and its role in metabolic homeostasis.

The researchers reported that MOTS-c influenced insulin sensitivity and metabolic pathways involving AMPK. In mouse models, administration of the peptide was associated with protection against diet-induced obesity and insulin resistance.

Another interesting area is exercise research. A 2021 study published in Nature Communications found that exercise increased endogenous MOTS-c expression in human skeletal muscle. The researchers also investigated its effects on physical performance in mice.

What remains unknown?​

Despite the interesting findings, there is an important distinction between observing endogenous MOTS-c in humans and administering synthetic MOTS-c.

The available evidence does not establish its safety or effectiveness as a treatment in humans. More controlled research is needed to understand its pharmacology, long-term effects and potential clinical relevance.

Discussion​

I find the connection between mitochondrial signaling and metabolic regulation particularly interesting.

Do you think mitochondrial-derived peptides like MOTS-c will become a major area of metabolic research, or is the current interest running ahead of the available evidence?

References:


Research materials: BP BioLabs

Shared for scientific and research discussion only.
 
Back
Top